Relationship between Osteoporosis Patient Outcomes for women with Breast Cancer

https://doi.org/10.55529/jpdmhd.33.9.21

Authors

  • Dr. Khamis Y. C. Al-Qubaeissy M.B.Ch.B \ MSc \ PhD \ (Rheumatologist & Physiatrist) Membership of ACR & BSR Iraqi Ministry of Health, Anbar Health Directorate, Al-Ramadi Teaching Hospital, Rheumatology Department, Anbar, Iraq.
  • Dr. Talib Mohammed Hasan Al-Musaedi M.B.Ch.B \ MSc \ (Rheumatologist & Physiatrist) Iraqi Ministry of Health, Al-Russafa Health Directorate, Al-Kindy Teaching Hospital, Rheumatology Department, Baghdad, Iraq.
  • Dr. Muna Sami Jassim M.B.Ch.B. \ MSc \ (Clinical Oncology) Member of the Iraqi Society of Clinical Oncology Iraqi Ministry of Health, Medical City, Al-Amal National Oncology Center Baghdad, Iraq.

Keywords:

Bones Density; Breast Cancer; Estrogen; and Osteoporosis.

Abstract

Introduction: Osteopenia, along with osteoporosis, all systemic skeletal disorders linked with different levels of bone loss, are common within postmenopausal female breast cancer survivors, despite earlier estimates indicating that up to 80% experience bone density loss. Objective: This paper aims to investigate the relationship between osteoporosis patient outcomes for women with breast cancer. Patients and methods: This paper was presented as a cross-sectional study about the evaluation relationship between osteoporosis patient outcomes for women with breast cancer. There were 150 participants in this data were almost participate within ages older than 30 and under than 65 years into Iraqi women in different hospitals in Iraq between 15th July 2021 to 27th August 2022. The analysed data included two groups, which are Group A and Group B; where group A represented patients were got breast cancer and struggle of osteoporosis, while Group B also have breast cancer and survived of osteoporosis. The data collected was analysed and designed by the SPSS program. Results and Discussion: A number of studies have shown that women about breast cancer suffer from a higher risk of fracture than women without cancer. However, the findings have proved so varied that smaller epidemiological investigations have evaluated the dangers of a condition known as well as osteoporosis in women in breast cancer compared to women without cancer in the exact same group. According to research, the first group has a higher incidence of bone density than the second since the primary reason is a lack of estrogen hormone in the first group, which promotes quicker bone loss. The researchers observed that individuals with group A breast cancer had a higher frequency of diminished bone density, including osteoporosis. They did not have a greater rate of bone loss at the start when compared to non-cancer women. Conclusion: In our conclusion, this study investigates that the patients with breast cancer are more injured to osteoporosis and bones loss as more than the group B patients due to the group A patients have a high density that led to have bones loss as well as impact on the treatment use while the second group patients have low bones density where that did not get bones lose. Furthermore, both groups found negative estrogen, but group B patients were better than the first. The risk factors result, found all the age, obesity, and bone density have a big impact on the patient's heart rate that, causes a loss in the heart rate.

Published

2023-04-20

How to Cite

Al-Qubaeissy, D. K. Y. C. ., Al-Musaedi, D. T. M. H. ., & Jassim, D. M. S. . (2023). Relationship between Osteoporosis Patient Outcomes for women with Breast Cancer. Journal of Prevention, Diagnosis and Management of Human Diseases (JPDMHD) 2799-1202, 3(03), 9–21. https://doi.org/10.55529/jpdmhd.33.9.21